Takeda Oncology

BioLife Plasma Services

Takeda Canada Inc.

TAKEDA IBDpoint

Innovation Capability Center at Takeda

Dengue Academy

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society.We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities.

PvP Biologics

Alnylam Pharmaceuticals

Xenon Pharmaceuticals

Avidity Biosciences

Ultragenyx Pharmaceutical

Maverick Therapeutics

Mersana Therapeutics

Molecular Templates

Naurex

Seagen

Bill & Melinda Gates Foundation

Takeda

Nipro Corporation is a Japanese company engaged in the development and production of medical devices and pharmaceutical products.

Nipro Corporation

Grifols is a Spanish multinational pharmaceutical and chemical company that specializes in the production of blood plasma-based products.

Grifols

Codiak Biosciences is a biotechnology company focused on the development of exosome-based therapeutics.

Codiak Biosciences

Amgen is an American multinational biopharmaceutical company that focuses on the development of innovative medicines for serious illnesses.

Amgen

Novartis is a Swiss multinational pharmaceutical company known for its research and development of innovative healthcare products.

Novartis

GSK, also known as GlaxoSmithKline, is a British multinational pharmaceutical company that focuses on the development of vaccines, medicines, and consumer healthcare products.

Pfizer is an American multinational pharmaceutical corporation known for its wide range of pharmaceutical products and vaccines.

Pfizer

Janssen, a subsidiary of Johnson & Johnson, is a global pharmaceutical company known for its research and development of innovative healthcare solutions.

Janssen

AbbVie is an American biopharmaceutical company known for its focus on developing advanced therapies for various medical conditions.

AbbVie

UCB is a multinational biopharmaceutical company that specializes in the research and development of treatments for severe diseases.

AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company known for its focus on developing innovative medicines in various therapeutic areas.

AstraZeneca

EMD Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, known for its focus on developing innovative therapies for patients with unmet medical needs.

EMD Serono

Bayer is a German multinational pharmaceutical and life sciences company known for its wide range of healthcare and agricultural products.

Bayer

Sanofi is a French multinational pharmaceutical company known for its focus on developing healthcare solutions in various therapeutic areas.

Sanofi

CSL Limited is an Australian multinational biotechnology company known for its focus on developing and delivering innovative biotherapies and influenza vaccines.

Novo Nordisk is a Danish multinational pharmaceutical company known for its focus on diabetes care and other serious chronic conditions.

Novo Nordisk

Octapharma is a Swiss-based global healthcare company known for its focus on developing and providing high-quality human proteins.

Octapharma

Roche is a Swiss multinational healthcare company known for its focus on innovative pharmaceuticals and diagnostics.

Roche

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on developing and delivering transformative therapies for patients with rare and special unmet medical needs.

Sanofi Genzyme

Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company known for its focus on developing innovative medicines for serious diseases.

Eli Lilly and Company is an American pharmaceutical company known for its focus on developing and delivering innovative medicines in various therapeutic areas.

Lilly

Gilead Sciences is an American biopharmaceutical company known for its focus on developing and delivering innovative treatments for life-threatening diseases.

Gilead

Teva Pharmaceutical Industries is an Israeli-American multinational pharmaceutical company known for its focus on developing and providing generic and specialty medicines.

TEVA

Abbott Laboratories is an American multinational medical devices and healthcare company known for its wide range of medical devices, diagnostics, and nutrition products.

Abbott

Mylan, now part of Viatris, is a global pharmaceutical company known for its focus on developing and delivering high-quality medicines to patients around the world.

Mylan

Takeda is a global, values-based, R&D-driven biopharmaceutical leader with a large U.S. presence. The company is committed to creating better health for people and a brighter future for the world through transformative treatments and a focus on diversity, equity, and inclusion.

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc.; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.

news impact assignment basic	general	Mar 7, 2024 3:34 PM	50fe2e49
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 7, 2024 3:34 PM	82c13344
company summary	general
signals	general	Mar 7, 2024 3:34 PM	140be5f4
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 7, 2024 3:34 PM	fa9f198d
translate crunchbase fundingrounds	general
peers	general	Mar 7, 2024 3:34 PM	ccc4b735
news basic	general	Mar 7, 2024 3:34 PM	5710dc29
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:TAKEDA

Takeda Pharmaceutical Company Limited

Last Close

4,182.00

21/11 06:45

Market Cap

6.77T

Beta: -

Volume Today

3.98M

Avg: -